Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection-Reference-Cited by-同舟云学术

Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection

Published:2020-05-17 Issue:12 Volume:92 Page:3507-3515
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Watanabe Takao¹,Tokumoto Yoshio¹,Joko Kouji²,Michitaka Kojiro³,Horiike Norio⁴,Tanaka Yoshinori⁵,Tada Fujimasa⁶,Kisaka Yoshiyasu⁷,Nakanishi Seiji⁸,Yamauchi Kazuhiko⁹,Yukimoto Atsushi¹,Nakamura Yoshiko¹,Hirooka Masashi¹,Abe Masanori¹,Hiasa Yoichi¹^ORCID

Affiliation:

1. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Ehime Japan

2. Center for Liver‐Biliary‐Pancreatic Diseases Matsuyama Red Cross Hospital Matsuyama Ehime Japan

3. Department of Gastroenterology Ehime Prefectural Central Hospital Matsuyama Ehime Japan

4. Department of Gastroenterology Saiseikai Imabari Hospital Imabari Ehime Japan

5. Department of Gastroenterology Matsuyama Shimin Hospital Matsuyama Japan

6. Department of Internal Medicine Saiseikai Matsuyama Hospital Matsuyama Ehime Japan

7. Department of Gastroenterology Uwajima City Hospital Uwajima Ehime Japan

8. Department of Gastroenterology Ehime Prefectural Imabari Hospital Imabari Ehime Japan

9. Department of Gastroenterology National Hospital Organization Ehime Medical Center Toon Ehime Japan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25984

Reference31 articles.

1. Hepatocellular carcinoma

2. Novel therapies for hepatitis C — one pill fits all?

3. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

4. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

5. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival and Cancer Risk in the Hepatitis C Virus-Infected Patients After Antiviral Treatment: A Nationwide Cohort Study;Journal of Cancer;2024

2. Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals;Scientific Reports;2023-06-02

3. Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals;2023-02-28

4. Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral;Cancers;2023-01-11

5. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV;Livers;2021-12-14